BioClinica ICL is that company's imagine core lab service, which supports clinical trials with imaging services.
N/A
Zelta
Score 8.0 out of 10
N/A
Zelta is a cloud-based unified clinical data management and acquisition platform with customizable modules, that can be tailored to the meet the needs of clinical trials and accelerate outcomes.
N/A
Pricing
Bioclinica ICL
Zelta
Editions & Modules
No answers on this topic
No answers on this topic
Offerings
Pricing Offerings
Bioclinica ICL
Zelta
Free Trial
No
No
Free/Freemium Version
No
No
Premium Consulting/Integration Services
No
Yes
Entry-level Setup Fee
No setup fee
Optional
Additional Details
—
Subscription - For larger organizations and those who need a predictable budget. Most modules included without incurring additional fees. Eligible for volume discounts.
Pay per use - For organizations that need flexibility without a long term contractual commitment. Transparent a la carte pricing, no minimums. Fees start when trial goes live.
BioClinica ICL is well suited for meeting the requirements for regulatory filling and submission support, imagining collection and QC, centralized independent review for consistency purposes, site training and imagining archiving and sharing. The Bioclinica team also assist you with creating the database based on the protocol and study design. Bioclinical ICL has all the features to meet the requirements for medical imagining but they can ensure that their interface is more intuitive and easy to use.
Zelta is a good tool for companies currently utilizing multiple software platforms to create and monitor clinical trial information. Due to the price, it is best suited for large pharmaceutical manufacturers with active pipelines and high R&D spend. Zelta's value is more limited to smaller, more focused companies.
Report generating should be more robust and up to date. Clinical trial sites receive multiple queries for the same images even after the sites have responded to the same query.
The webiste to upload images by the site is good but I have used other similar software which is more intuitive and easy to maneuver.
We cannot have multiple study accesses for a study in the studies supported by Zelta. eg. Coder and Data manager.
Though all the study-build related errors are flagged on the study-build page, some errors like incorrect dynamics applied, which eventually affects the subject PDF extraction, reports, etc.
When the study is imported from another Zelta studies, certain attributes remain running in the background even if it seems to be disabled.
We are satisfied from our experience with Zelta by Merative, the close collaboration we have with the Zelta team is also something we value. We plan to use Zelta for a long time
Zelta has many different functionalities as well as modules that can be used depending on what the sponsor wants. I like that they are optional so that when building a study, you can give the sponsor options if they want them or not. Many of the optional models I like to use (Training Tracking for example) as they make tracking Site training so much easier than sending training forms out.
Our organization has been using both Zelta and in-house applications. The main considerations on which one to use for a particular study is time to get the databases running, cost, and ease of use. For some studies, the time and cost of using Zelta are negative factors, and an in-house system is selected.
Parexel also has the capability to collect medical images in a central repository database. Parexel's uploading website is very intuitive and very easy to use. BioClinica can easily ensure that their uploading website is more user-friendly and the interface is easy to understand. Overall Bioclinica ICL is a very good option for pharmaceutical or biotechnology companies.
It was easier to understand the usability of the software [Zelta]. For our engineers [it] was easier to migrate our data, and fully set up everything. We found out that comparing other software[s], this one is safe, easy to use, has more functionalities, [and it's] easier to work with team members everywhere making clinical trials more efficient.
